Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the rate used by Aptose in its financial reporting in accordance with International Financial Reporting Standards.
Appears in 4 contracts
Samples: License Agreement (Aptose Biosciences Inc.), Option and License Agreement (Aptose Biosciences Inc.), Option and License Agreement
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the closing exchange rate used by Aptose reported in its financial reporting in accordance with International Financial Reporting StandardsThe Wall Street Journal for the last Business Day of the applicable calendar quarter.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Aradigm Corp), License and Collaboration Agreement (Savara Inc), License, Market Development and Commercialization Agreement (Derma Sciences, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the rate used by Aptose average of the closing exchange rates reported in its financial The Wall Street Journal over the applicable reporting in accordance with International Financial Reporting Standardsperiod.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Intra-Cellular Therapies, Inc.), License and Collaboration Agreement (Intra-Cellular Therapies, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the applicable spot exchange rate used sourced from Reuters/Bloomberg, or such other source agreed to by Aptose in its financial reporting in accordance with International Financial Reporting Standardsboth Parties.
Appears in 2 contracts
Samples: Exclusive License Agreement (Intrexon Corp), Exclusive License Agreement (Ziopharm Oncology Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the rate used by Aptose Oncoheroes in its financial reporting in accordance with International Financial Reporting Accounting Standards, as applicable.
Appears in 2 contracts
Samples: Exclusive License Agreement (Allarity Therapeutics, Inc.), Exclusive License Agreement (Allarity Therapeutics, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the rate used by Aptose average of the daily closing exchange rates reported in its financial The Wall Street Journal (U.S., Western Edition) over the applicable reporting in accordance with International Financial Reporting Standardsperiod for the payment due.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Kalobios Pharmaceuticals Inc), Collaboration and License Agreement (Kalobios Pharmaceuticals Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales Profits and Sublicensing Income invoiced in other currencies shall be the rate used by Aptose in its financial reporting in accordance with International Financial Reporting Standardsmade at [* * *].
Appears in 2 contracts
Samples: License and Collaboration Agreement (Targacept Inc), License and Collaboration Agreement (Targacept Inc)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the rate used by Aptose Verrica in its financial reporting in accordance with International Financial Reporting Accounting Standards, as applicable.
Appears in 1 contract
Samples: Exclusive License Agreement (Verrica Pharmaceuticals Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the rate used by Aptose in its financial average of the interbank rates reported at XXXXX.XXX over the applicable reporting in accordance with International Financial Reporting Standardsperiod for the payment due.
Appears in 1 contract
Samples: License and Collaboration Agreement (Signal Genetics, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be the rate used by Aptose Elanco in its financial reporting in accordance with International Financial Reporting StandardsU.S. GAAP, as applicable.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Kindred Biosciences, Inc.)
Foreign Exchange. The rate of exchange to be used in computing the amount of currency equivalent in Dollars of Net Sales invoiced in other currencies shall be made at the monthly rate used of exchange utilized by Aptose in its financial reporting Licensee, in accordance with International Financial Reporting StandardsGAAP, fairly applied and as employed on a consistent basis.
Appears in 1 contract
Samples: License Agreement (Medifocus Inc.)
